Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04752930
Status:
RECRUITING
Last Update Posted:
2021-02-12
First Post:
2021-01-26
Brief Title:
ctDNA as a Assisted Diagnosis Early Intervention and Prognostic Marker for Peritoneal Metastases From Colorectal Cancer
Sponsor:
Sixth Affiliated Hospital Sun Yat-sen University
Organization:
Sixth Affiliated Hospital Sun Yat-sen University
Study Overview
Official Title:
Circulating Tumor DNA ctDNA as a Assisted Diagnosis Early Intervention and Prognostic Marker for Peritoneal Metastases From Colorectal Cancer A Prospective Open-label Randomized Controlled Study
Status:
RECRUITING
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective open-label randomized controlled clinical trial by monitoring the serum ctDNA mutational profile using NGS aiming to elucidate the correlation between the postoperative ctDNA status and the assisted diagnosis early intervention and prognosis for colorectal cancer peritoneal metastases
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None